false 0001047335 0001047335 2023-11-03 2023-11-03
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 3, 2023 (November 3, 2023)
 

 
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 

 
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
 
 
37130
(Zip Code)
 
Registrants telephone number, including area code: (615) 890-2020
 
Not Applicable
(Former name or former address, if changed since last report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
ITEM 2.02.         RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
National HealthCare Corporation (“NHC”) issued a press release on November 3, 2023, announcing its September 30, 2023 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
ITEM 9.01.         FINANCIAL STATEMENTS AND EXHIBITS.
 
(d)         Exhibits.
 
Exhibit No.
 
Description of Exhibit
99.1
 
     
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:         November 3, 2023
 
 
NATIONAL HEALTHCARE CORPORATION
 
       
       
 
By: /s/
Brian F. Kidd
 
  Name: Brian F. Kidd  
  Title: Senior VP/Chief Financial Officer  
 
 

Exhibit 99.1

 

 

a01.jpg

 

For release: November 3, 2023

Contact: Brian F. Kidd, SVP/Chief Financial Officer

Phone: (615) 890-2020

 

NHC Reports Third Quarter 2023 Earnings

 

MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2023 totaled $288,485,000 compared to $270,843,000 for the quarter ended September 30, 2022, an increase of 6.5%. Excluding the seven skilled nursing facilities in Massachusetts and New Hampshire in which we ceased operations in September 2022, same-facility net operating revenues increased 11.8% during the third quarter of 2023 compared to the same period a year ago.

For the quarter ended September 30, 2023, the reported GAAP net income attributable to NHC was $10,388,000 compared to a net loss of $2,429,000 for the same period in 2022. Excluding the unrealized gains or losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended September 30, 2023 was $13,250,000 compared to $7,783,000 for the same period in 2022 (*). The increase in non-GAAP earnings for the quarter ended September 30, 2023 compared to the third quarter of 2022 was primarily due to the continued occupancy increase in our skilled nursing and assisted living facilities, skilled nursing per diem increases from some of our government payors, and the continued reduction of nurse agency staffing expenses within our operations. The GAAP diluted earnings per share was $0.68 for the quarter ended September 30, 2023 compared to a loss per share of $(0.16) for the quarter ended September 30, 2022. Adjusted diluted earnings per share were $0.86 and $0.50 for the quarters ended September 30, 2023 and 2022, respectively (*).

 

(*) -          See the tables below that provide a reconciliation of GAAP to non-GAAP items.

 

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,732 beds. NHC affiliates also operate 26 assisted living communities with 1,501 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

 

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

 

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

 

-more-

 

 

 

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30

   

September 30

 
   

2023

   

2022

   

2023

   

2022

 
   

(unaudited)

   

(unaudited)

 

Revenues and grant income:

                               

Net patient revenues

  $ 277,005     $ 260,247     $ 804,617     $ 776,661  

Other revenues

    11,480       10,596       36,013       33,584  

Government stimulus income

    -       -       -       10,940  

Net operating revenues and grant income

    288,485       270,843       840,630       821,185  
                                 

Costs and expenses:

                               

Salaries, wages and benefits

    182,664       173,198       525,782       518,828  

Other operating

    72,490       72,883       217,213       218,279  

Facility rent

    10,094       10,294       30,087       30,770  

Depreciation and amortization

    10,135       10,253       30,266       30,011  

Interest

    77       137       268       451  

Impairment/(recovery) of assets

                               

Total costs and expenses

    275,460       266,765       803,616       798,339  
                                 

Income from operations

    13,025       4,078       37,014       22,846  
                                 

Non-operating income

    4,097       2,731       12,116       8,451  

Unrealized gains/(losses) on marketable equity securities

    (3,093 )     (11,056 )     2,943       (11,479 )
                                 

Income/(loss) before income taxes

    14,029       (4,247 )     52,073       19,818  

Income tax (provision)/benefit

    (3,908 )     1,140       (14,750 )     (5,415 )

Net income/(loss)

    10,121       (3,107 )     37,323       14,403  
                                 

Net loss attributable to noncontrolling interest

    267       678       1,069       1,689  
                                 

Net income/(loss) attributable to National HealthCare Corporation

  $ 10,388     $ (2,429 )   $ 38,392     $ 16,092  
                                 

Net income/(loss) per common share

                               

Basic

  $ 0.68     $ (0.16 )   $ 2.51     $ 1.04  

Diluted

  $ 0.68     $ (0.16 )   $ 2.50     $ 1.04  
                                 

Weighted average common shares outstanding

                               

Basic

    15,299,913       15,445,569       15,311,453       15,438,375  

Diluted

    15,324,511       15,445,569       15,334,269       15,477,103  
                                 

Dividends declared per common share

  $ 0.59     $ 0.57     $ 1.75     $ 1.69  

 

Balance Sheet Data

 

September 30

   

December 31

 

(in thousands)

 

2023

   

2022

 
   

(unaudited)

         
                 

Cash, cash equivalents and marketable securities

  $ 210,494     $ 182,589  

Restricted cash, cash equivalents and marketable securities

    162,492       158,067  

Current assets

    382,578       353,932  

Property and equipment, net

    498,266       506,532  

Total assets

    1,281,907       1,275,450  

Current liabilities

    204,694       197,887  

Stockholders' equity

    887,340       877,514  

 

-more-

 

 

 

Selected Operating Statistics

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30

   

September 30

 
   

2023

   

2022

   

2023

   

2022

 
   

(unaudited)

   

(unaudited)

 

Skilled Nursing Per Diems:

                               

Medicare

  $ 551.82     $ 535.60     $ 552.21     $ 540.30  

Managed Care

    489.18       429.22       460.20       425.39  

Medicaid

    256.46       237.61       248.99       230.79  

Private Pay and Other

    283.49       265.68       279.12       268.13  
                                 

Average Skilled Nursing Per Diem

  $ 325.34     $ 302.43 (1)   $ 320.09     $ 301.91 (1)
                                 

Skilled Nursing Patient Days:

                               

Medicare

    75,215       81,940       239,228       258,961  

Managed Care

    61,979       52,956       179,992       163,823  

Medicaid

    290,887       302,500       852,074       919,931  

Private Pay and Other

    170,857       169,068       492,279       489,477  
                                 

Total Skilled Nursing Patient Days

    598,938       606,464 (1)     1,763,573       1,832,192 (1)

 

(1) For the three and nine months ended September 30, 2022, the skilled nursing per diems and patient days listed above include the seven skilled nursing facilities that were located in Massachusetts and New Hampshire through August 31, 2022.  NHC exited these seven skilled nursing facilities on September 1, 2022.  For the three months ended September 30, 2022, the exited Massachusetts and New Hampshire skilled nursing facilities had an average skilled nursing per diem of $295.98 and 35,619 total patient days. For the nine months ended September 30, 2022, the exited Massachusetts and New Hampshire skilled nursing facilities had an average skilled nursing per diem of $294.64 and 140,105 total patient days.

 

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30

   

September 30

 
   

2023

   

2022

   

2023

   

2022

 
   

(unaudited)

   

(unaudited)

 
                                 

Net income/(loss) attributable to National Healthcare Corporation

  $ 10,388     $ (2,429 )   $ 38,392     $ 16,092  

Non-GAAP adjustments

                               

Unrealized (gains)/losses on marketable equity securities

    3,093       11,056       (2,943 )     11,479  

Operating results for newly opened operations not at full capacity (2)

    66       2,105       1,616       4,033  

Stock-based compensation expense

    708       639       2,119       1,980  

Income tax (benefit)/provision on non-GAAP adjustments

    (1,005 )     (3,588 )     (206 )     (4,548 )

Non-GAAP Net income

  $ 13,250     $ 7,783     $ 38,978     $ 29,036  
                                 

GAAP diluted earnings/(loss) per share

  $ 0.68     $ (0.16 )   $ 2.51     $ 1.04  

Non-GAAP adjustments

                               

Unrealized (gains)/losses on marketable equity securities

    0.15       0.53       (0.14 )     0.56  

Operating results for newly opened operations not at full capacity (2)

    -       0.10       0.07       0.19  

Stock-based compensation expense

    0.03       0.03       0.10       0.09  

Non-GAAP diluted earnings per share

  $ 0.86     $ 0.50     $ 2.54     $ 1.88  

 

(2) The newly opened operations not at full capacity for the 2023 periods presented consisted of operations opened from 2021 through 2023.  This consisted of two behavioral health hospitals, two homecare agencies, and two hospice agencies.  The newly opened operations for the 2022 periods presented consisted of operations opened from 2020 through 2022.  This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency.

 

 
v3.23.3
Document And Entity Information
Nov. 03, 2023
Document Information [Line Items]  
Entity, Registrant Name NATIONAL HEALTHCARE CORPORATION
Document, Type 8-K
Document, Period End Date Nov. 03, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-13489
Entity, Tax Identification Number 52-2057472
Entity, Address, Address Line One 100 E. Vine Street
Entity, Address, City or Town Murfreesboro
Entity, Address, State or Province TN
Entity, Address, Postal Zip Code 37130
City Area Code 615
Local Phone Number 890-2020
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol NHC
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001047335

National HealthCare (AMEX:NHC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse National HealthCare
National HealthCare (AMEX:NHC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse National HealthCare